Cancer feature: cnaPANCAN107

AC002310.13 AHSP ALDOA ARMC5 ASPHD1 BCKDK BCL7C BOLA2B C16orf58 C16orf92 C16orf93 C16orf98 CD2BP2 CDIPT CORO1A COX6A2 CTF1 DCTPP1 DOC2A FAM57B FBRS FBXL19 FUS GDPD3 HIRIP3 HSD3B7 INO80E ITGAD ITGAL ITGAM ITGAX KAT8 KCTD13 MAPK3 MYLPF ORAI3 PHKG2 PPP4C PRR14 PRSS36 PRSS53 PRSS8 PYCARD PYDC1 RNF40 RP11-196G11.1 RP11-347C12.1 RP11-347C12.3 SEPHS2 SEPT1 SETD1A SEZ6L2 SLC5A2 SLX1A SRCAP STX1B STX4 SULT1A3 TAOK2 TBC1D10B TBX6 TGFB1I1 TMEM219 TRIM72 VKORC1 YPEL3 ZNF48 ZNF629 ZNF646 ZNF668 ZNF688 ZNF689 ZNF720 ZNF747 ZNF747 ZNF764 ZNF768 ZNF771 ZNF785 ZNF843

Known Driver Genes: None

Copy number alternation: gain

CCT-018159

The Genomics of Drug Sensitivity in Cancer Project is a collaboration between the Cancer Genome Project at the Wellcome Sanger Institute (UK) and the Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center (USA). This work is funded by Wellcome.

Users have a non-exclusive, non-transferable right to use data files for internal proprietary research and educational purposes, including target, biomarker and drug discovery. Excluded from this licence are use of the data (in whole or any significant part) for resale either alone or in combination with additional data/product offerings, or for provision of commercial services.
Please note: The data files are experimental and academic in nature and are not licensed or certified by any regulatory body. Genome Research Limited provides access to data files on an “as is” basis and excludes all warranties of any kind (express or implied).

Genomics of Drug Sensitivity in Cancer